CN1296086C - Medicine for treating cancer and its preparing method - Google Patents
Medicine for treating cancer and its preparing method Download PDFInfo
- Publication number
- CN1296086C CN1296086C CNB2005100126087A CN200510012608A CN1296086C CN 1296086 C CN1296086 C CN 1296086C CN B2005100126087 A CNB2005100126087 A CN B2005100126087A CN 200510012608 A CN200510012608 A CN 200510012608A CN 1296086 C CN1296086 C CN 1296086C
- Authority
- CN
- China
- Prior art keywords
- medicine
- cancer
- treatment
- radix
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a Chinese patent medicine for treating cancer, which is prepared by that gecko, edible tulip, cambogia, rhodiola root, musk, notoginseng, aulastomum gulo, hairy antler, etc. are used as raw materials; according to different properties of the raw materials, the raw materials are proportionally prepared after the processes of extraction with water, concentration drying, pulverization and direct pulverization, and then capsules are obtained after sterilization. The present invention has the functions of strengthening congenital activity and disease resistance of human bodies, inhibiting cancer cell growth, killing cancer cells with medicines, dissipating tumours, eliminating inflammation with medicines and removing toxin. The present invention integrates steps for treating cancer, and has obvious therapeutic effect on various kinds of cancer.
Description
Affiliated technical field
The present invention relates to a kind of medicine for the treatment of cancer, particularly relating to a kind of is the Chinese patent medicine of the treatment cancer of feedstock production with Chinese medicine.The invention still further relates to the preparation method of this medicine.
Background technology
At present, domestic and treat method for cancer in the world and perform a surgical operation basically, and cooperate with radiotherapy or chemotherapy.Operative treatment startles cancerous tissue static cancerous cell on every side easily as digging tree, and it is active that immobilized cancerous cell is taken place, transfer and relapse, and not only treatment is greatly painful, and can not eradicate cancer.Radiation and chemotherapy had had both killed and wounded cancerous cell, killed and wounded normal cell again, and suppressed hematopoietic function, reduced immune function of human body, and side effect is very big.
Adopting the treatment by Chinese herbs cancer is a feasible approach.But present treatment by Chinese herbs cancer drug all is to use the Therapeutic Principle for the treatment of the poisonous disease with poisonous drugs, do not consider the factor that strengthens the congenital vigor of cancer patient's body, so therapeutic effect is not remarkable.
Summary of the invention
The purpose of this invention is to provide the congenital vigor of a kind of enhancing human body, strengthening the body resistance, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, analgesic treatment cancer Chinese Traditional Medicines.
The preparation method of this medicine is provided, and is another goal of the invention of the present invention.
Treatment mechanism of the present invention is at first strengthening the body resistance, YIN and YANG balance regulating, strengthens the congenital vigor of human body, improves self anticancer power, the anticancer growth; Secondly heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, pain relieving dampness removing to diminish inflammation, are removed toxin; Reuse the medicine brute force and attack killing cancer cell, tumor is dissipated, three steps one treatment cancer.
Medicine of the present invention specifically is to be made by the raw material of following weight ratio:
Gekko Swinhonis 2～8 Pseudobulbus cremastrae seu pleiones 3～10
Resina garciniae 0.01～0.1 Radix Rhodiolae 3～10
Moschus 0.01～0.1 Radix Notoginseng 3～10
Hirudo 3～10 Cornu Cervi Pantotrichums 0.3～1.5
Fructus Bruceae 0.3～1.5 Calculus Bovis 0.1～1
Carapax Trionycis 5～20 Bufo siccuss 0.01～0.03
Propolis 0.5～3 Radix Ginseng 0.5～3
Endothelium Corneum Gigeriae Galli 0.5～3 Borneolum Syntheticum 0.01～0.2.
Above-mentioned each component can be made said dosage form on any pharmaceutics, and the preferred dosage form of the present invention is a capsule.
Above-mentioned each component is made medicine production method of the present invention is:
1, get Radix Ginseng, Cornu Cervi Pantotrichum, Calculus Bovis, Moschus, Bufo siccus, Resina garciniae, propolis, Fructus Bruceae, Endothelium Corneum Gigeriae Galli, Borneolum Syntheticum, mixed powder is broken into 100～120 order fine powders according to the above ratio;
2, get Radix Rhodiolae, Pseudobulbus cremastrae seu pleiones, Gekko Swinhonis, Carapax Trionycis, Hirudo, Radix Notoginseng, mix according to the above ratio, extracting in water three times discards residue, and extracting solution is concentrated, dry, is ground into 100～120 order fine powders;
3, with above-mentioned whole fine powder mix homogeneously, in incapsulating after the sterilization, make capsule.
In the prescription of the present invention, Radix Ginseng, Cornu Cervi Pantotrichum, propolis strengthening the body resistance, strongly invigorating primordial QI, kidney invigorating and YANG supporting, the smart marrow of mending of benefit have the raising human body immunity, impel hematopoietic function, effectively the effect of anticancer growth; Resina garciniae, Bufo siccus, Gekko Swinhonis treating the poisonous disease with poisonous drugs, the phagedenoma of assaulting fortified position, drastically removing blood stasis and resolving static blood, elimination lump have direct toxic action to cancerous cell; Calculus Bovis, Fructus Bruceae, Radix Rhodiolae heat-clearing and toxic substances removing dampness removing can diminish inflammation, the vivotoxin of degrading, remove lump; Hirudo, Radix Notoginseng, Pseudobulbus cremastrae seu pleiones, Moschus, Carapax Trionycis, Endothelium Corneum Gigeriae Galli blood circulation promoting and blood stasis dispelling, hard masses softening and resolving pain relieving, can reduce hematoblastic adhesion and aggregation, reduce fibrinogenic content, increase fibrinous dissolving, blood vessel dilating, blood flow increasing improves the high blood coagulable status of blood circulation and body, tumor cell is under the dual control of body's immunity and cancer therapy drug, and lump dissipates as early as possible.More than all medicine compatibilities, can strengthen the congenital vigor and the resistance against diseases of human body, the anticancer growth, attack killing cancer cell with the medicine brute force, tumor is dissipated, while diminishes inflammation, removes toxin with the medicine of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, heat-clearing and toxic substances removing, pain relieving dampness removing again, and three steps one treatment cancer all has notable therapeutic effect for all kinds of cancers.
For showing medicine of the present invention to the treatment for cancer effect, the present invention has carried out clinical observation on the therapeutic effect to 61 routine cancer patients, wherein,
Hepatocarcinoma case 15 examples, essence occupy-place in the CT scan diagnosis liver, the biochemical analysis alpha-fetoprotein is positive;
Esophageal carcinoma case 16 examples, x-ray, CT scan diagnosis, splanchnoscopy are made a definite diagnosis swollen thing in the esophagus, and cytolgical examination has cancerous cell, the biochemical analysis anemia, plasma protein reduces;
Cancer of pancreas case 6 examples, ultrasonic, CT scan diagnosis has substantive occupy-place, and biochemical analysis serum amylase, lipase, protease raise;
Breast carcinoma case 16 examples, xerogram, CT scan are found focus, the lump aspiration biopsy is positive;
Uterus carcinoma case 3 examples, colposcopy, it is positive to get biopsy;
Osteocarcinoma case 15 examples, CT scan has substantive occupy-place.
More than 61 routine cases all be diagnosed as cancer, take Drug therapy of the present invention, one month is a course of treatment, takes 3～12 courses of treatment continuously.
According to the traditional Chinese medical science curative effect judging standard of China's treatment cancer,
Cure: the positive sign complete obiteration of symptom and objective determination, recover certain labour force, observe continuously more than 3 years and do not have the recidivist.
Clinical cure: the positive sign of symptom and objective determination disappears,
1 grade: observing continuously more than 1 year does not have the recidivist;
2 grades: observe year no recidivist half a year to one continuously;
3 grades: observe 2～6 months no recidivists continuously.
Produce effects: symptom disappears substantially, and focus is dwindled over half, and basic objective determination takes an evident turn for the better,
1 grade: observe more than half a year no longer development person;
2 grades: observe 2～6 months no longer development persons.
Effectively: symptom makes moderate progress, and focus is basicly stable, observes person more than month.
Invalid: symptom and objective determination do not have improvement, or only have short-term to improve and deterioration person rapidly.
61 routine clinical patients therapeutic outcomes are carried out comprehensive statistics, cure rate 39.3%, clinical cure rate 44.3%, total effective rate 98.4%, concrete data see Table 1.
Table 1 clinical drug therapeutic effect statistics of the present invention
| Case load | Cure | Clinical cure | Produce effects | Invalid | |
| Hepatocarcinoma | 15 | 4 | 8 | 3 | |
| Esophageal carcinoma | 16 | 5 | 9 | 2 | |
| Cancer of pancreas | 6 | 2 | 3 | 1 | |
| Breast carcinoma | 16 | 10 | 5 | 1 | |
| Uterus carcinoma | 3 | 1 | 1 | 1 | |
| Osteocarcinoma | 15 | 2 | 2 | 1 | |
| Amount to | 61 | 24 | 27 | 9 | 1 |
Table 2 is biochemistry detection data that one group of hepatocarcinoma and Pancreas cancer patients are taken medicine of the present invention front and back, by the variation of biochemical indicator value, proves that medicine of the present invention has certain effect really for the treatment cancer.
The biochemistry detection data contrasted before and after table 2 was taken medicine of the present invention
| Hepatocarcinoma | Cancer of pancreas | ||||||
| Alpha antitrypsin (the mg/dl of α-AT) | Alpha-fetoprotein (AFP) μ g/L | Alkali phosphatase (ALP) | Lactic acid dehydrogenase (LDH) u/L | ||||
| Before the treatment | After the treatment | Before the treatment | After the treatment | Before the treatment | After the treatment | Before the treatment | After the treatment |
| ＞420 | ＜320 | ＞400 | ＜50～＜25 | ＞100 | ＜40 | ＞450 | ＜350～＜100 |
The specific embodiment
Embodiment 1:
Take by weighing raw material (Kg) by following proportioning:
Gekko Swinhonis 5 Pseudobulbus cremastrae seu pleiones 10 Resina garciniaes 0.05
Radix Rhodiolae 5 Moschus 0.05 Radix Notoginseng 10
Hirudo 8 Cornu Cervi Pantotrichums 1 Fructus Bruceae 1
Calculus Bovis 0.5 Carapax Trionycis 10 Bufo siccuss 0.01
Propolis 2 Radix Ginsengs 2 Endothelium Corneum Gigeriae Galli 3
Borneolum Syntheticum 0.05
Concrete production method is earlier with Radix Rhodiolae; Pseudobulbus cremastrae seu pleiones; Gekko Swinhonis; Carapax Trionycis; Hirudo; Radix Notoginseng Six-element Chinese medicine is mixed in proportion; decoct with water extraction; extract altogether three times; merge three times decocting liquid; discard residue; decocting liquid is concentrated into thick paste; and behind the further bake drying; be ground into 120 order fine powders, again with Radix Ginseng; Cornu Cervi Pantotrichum; Calculus Bovis; Moschus; Bufo siccus; Resina garciniae; propolis; Fructus Bruceae; Endothelium Corneum Gigeriae Galli; Borneolum Syntheticum ten flavor Chinese medicines are mixed in proportion, and are ground into 120 order fine powders; join in the above-mentioned oven dry fine powder; fully mix homogeneously during the sterilization back incapsulates by every 0.5g, is made capsule.
Embodiment 2:
Take by weighing raw material (Kg) by following proportioning:
Gekko Swinhonis 6 Pseudobulbus cremastrae seu pleiones 5 Resina garciniaes 0.02
Radix Rhodiolae 10 Moschus 0.02 Radix Notoginseng 5
Hirudo 5 Cornu Cervi Pantotrichums 1.2 Fructus Bruceaes 0.8
Calculus Bovis 0.3 Carapax Trionycis 15 Bufo siccuss 0.02
Propolis 1 Radix Ginseng 3 Endothelium Corneum Gigeriae Galli 1
Borneolum Syntheticum 0.1
Production method is with embodiment 1.
Claims (4)
1, a kind of medicine for the treatment of cancer is characterized in that making active component raw material and is made up of the component of following weight proportioning:
Gekko Swinhonis 2～8 Pseudobulbus cremastrae seu pleiones 3～10
Resina garciniae 0.01～0.1 Radix Rhodiolae 3～10
Moschus 0.01～0.1 Radix Notoginseng 3～10
Hirudo 3～10 Cornu Cervi Pantotrichums 0.3～1.5
Fructus Bruceae 0.3～1.5 Calculus Bovis 0.1～1
Carapax Trionycis 5～20 Bufo siccuss 0.01～0.03
Propolis 0.5～3 Radix Ginseng 0.5～3
Endothelium Corneum Gigeriae Galli 0.5～3 Borneolum Syntheticum 0.01～0.2.
2, the medicine of treatment cancer according to claim 1 is characterized in that said medicament is a said dosage form on any pharmaceutics.
3, the medicine of treatment cancer according to claim 2 is characterized in that said medicament is a capsule.
4, the preparation method of the medicine of the described treatment cancer of claim 3 is characterized in that getting earlier Radix Ginseng, Cornu Cervi Pantotrichum, Calculus Bovis, Moschus, Bufo siccus, Resina garciniae, propolis, Fructus Bruceae, Endothelium Corneum Gigeriae Galli, Borneolum Syntheticum, and mixed powder is broken into 100～120 order fine powders according to the above ratio; Get Radix Rhodiolae, Pseudobulbus cremastrae seu pleiones, Gekko Swinhonis, Carapax Trionycis, Hirudo, Radix Notoginseng, mix according to the above ratio, extracting in water three times discards residue, and extracting solution is concentrated, dry, is ground into 100～120 order fine powders; With above-mentioned whole fine powder mix homogeneously, in incapsulating after the sterilization, make capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100126087A CN1296086C (en) | 2005-06-13 | 2005-06-13 | Medicine for treating cancer and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100126087A CN1296086C (en) | 2005-06-13 | 2005-06-13 | Medicine for treating cancer and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1709316A CN1709316A (en) | 2005-12-21 |
| CN1296086C true CN1296086C (en) | 2007-01-24 |
Family
ID=35705648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100126087A Expired - Fee Related CN1296086C (en) | 2005-06-13 | 2005-06-13 | Medicine for treating cancer and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1296086C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101164551B (en) * | 2006-10-16 | 2010-05-26 | 三峡大学 | Optimized formula for liver cancer-resisting traditional Chinese medicine active ingredient |
| CN101554417B (en) * | 2008-04-08 | 2011-09-21 | 南京中科集团股份有限公司 | Quality control method of antitumor Chinese medicine composition |
| CN102908529B (en) * | 2012-11-22 | 2013-12-25 | 孙迎春 | Traditional Chinese medicine for treating lung cancer |
| CN104547313B (en) * | 2013-10-12 | 2017-09-08 | 刘长源 | It is a kind of to treat lung cancer, breast cancer, the medicine of lymph cancer and preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1104907A (en) * | 1994-07-01 | 1995-07-12 | 柳毅 | Medicine for curing tumour |
| CN1270040A (en) * | 2000-03-13 | 2000-10-18 | 徐忠廷 | Anti-cancer Chinese-medicinal pill |
-
2005
- 2005-06-13 CN CNB2005100126087A patent/CN1296086C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1104907A (en) * | 1994-07-01 | 1995-07-12 | 柳毅 | Medicine for curing tumour |
| CN1270040A (en) * | 2000-03-13 | 2000-10-18 | 徐忠廷 | Anti-cancer Chinese-medicinal pill |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1709316A (en) | 2005-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1296086C (en) | Medicine for treating cancer and its preparing method | |
| CN1472220A (en) | Triterpene extracts from achyranthes roots and their use in medicine against osteoporosis | |
| CN1927240A (en) | Traditional Chinese medicine mask composition for depigmenting | |
| CN1966067A (en) | Medicament for treating aplastic anemia | |
| CN1785330A (en) | Medicine for treating high blood pressure and its preparation method | |
| CN1695682A (en) | External use preparation for treating rheumatisma and bone injuries | |
| CN101036723A (en) | Effective Chinese traditional medicine having a function of invigorating kidney and strengthening resistance and solidifying health | |
| CN1772257A (en) | Fatty liver treating notoginseng prepn and its prepn process | |
| CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
| CN1943691A (en) | A Chinese traditional medicinal composition for treatment of osteoporosis and its preparation method | |
| CN1785240A (en) | Dripping pills used for treating coronary heart disease and its prepn. method | |
| CN1850248A (en) | Chinese medicine capsule for treating hyperplasia mammary glands and preparing method | |
| CN100346812C (en) | Medicine for treating hyperplasia of mammary glands and fibroadenoma of breast and prepn. technique | |
| CN1939494A (en) | Purge capsules for old person and production thereof | |
| CN1723956A (en) | Medicine for treating chronic gastritis and gastric carcinoma, and its prepn. method | |
| CN1875976A (en) | Use of tanshinone compound in preparation of medicine for treating prostate hyperplasia | |
| CN100344319C (en) | Chinese medicine composition for treating urogenital system disease and its preparing method and use | |
| CN1903255A (en) | Traditional Chinese medicine prepn. for treating osteoporosis | |
| CN1745802A (en) | Plaster for treating pain and prpearation thereof | |
| CN1298371C (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
| CN1297303C (en) | Tumor eliminating powder | |
| CN1264565C (en) | Anti-senility plaster | |
| CN1286480C (en) | Oral disintegrants of composite salvia miltiorrhiza and their preparation | |
| CN1140281C (en) | Yiyuansan powder as one orally taken medicine for treating liver cancer and its preparation | |
| CN1836707A (en) | Medicine for treating tumour and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |